How to Get Foundayo (Orforglipron) Without Insurance in 2026
Foundayo's list price is approximately $1,099 per month - but the realistic cash-pay floor is much lower. LillyDirect self-pay starts at $149/month for the lowest dose, up to $299/month for higher doses within the 45-day refill window. Below are the cash-pay paths ranked by typical out-of-pocket cost in May 2026.
Cash-pay Foundayo paths at a glance
| Path | Monthly | Annual |
|---|---|---|
| Medicare Part D (from July 1, 2026) | $50 | $600 |
| LillyDirect self-pay (lowest dose) | $149 | $1,788 |
| LillyDirect self-pay (mid-range doses) | $299 | $3,588 |
| LillyDirect self-pay (14.5 / 17.2 mg out of window) | $349 | $4,188 |
| Retail pharmacy (CVS, Walgreens) - cash | Varies, ~$200-$300 | ~$2,400-$3,600 |
| Telehealth (Ro and others) | Varies | Varies |
| Cash retail (full WAC) | $1,099 | $13,188 |
1. LillyDirect self-pay ($149-$299/mo)
LillyDirect is Eli Lilly's direct-to-patient channel for Foundayo. It is the cheapest cash-pay path in May 2026: $149/month for the lowest dose, up to $299/month for higher doses, all within the 45-day refill window. Available since April 6, 2026, five days after FDA approval. Includes a telehealth prescriber visit if you do not have an existing prescription.
For the highest doses (14.5 mg and 17.2 mg), pricing moves to $349/month standard if you let the refill window lapse beyond 45 days. Set a calendar reminder for day 30 of your supply to stay in-tier.
Visit LillyDirect →2. Medicare Part D ($50/mo from July 1, 2026)
Eligible Medicare Part D enrollees may pay as low as $50/month beginning July 1, 2026 per Eli Lilly's announced launch terms. The Medicare Modernization Act of 2003 statutorily excludes drugs prescribed solely for weight loss from Part D, but Lilly has structured Foundayo pricing to include Medicare-eligible patients at the $50/month tier.
What to do: after July 1, 2026, contact your Part D plan administrator and confirm Foundayo is on formulary at the Lilly-set tier. Medicare Advantage plans handle GLP-1s plan-by-plan; coverage varies. Medicaid coverage is state-by-state and not yet broadly established for Foundayo as of May 2026.
3. Retail pharmacy pickup (CVS, Walgreens, ~$200-$300/mo cash)
Retail pharmacies have carried Foundayo since April 9, 2026, eight days after FDA approval. CVS, Walgreens, and most major chains stock it. Cash price varies pharmacy-to-pharmacy but typically runs $200-$300/month for the lowest dose due to dispensing fees and retail margin on top of the wholesale acquisition cost.
Use retail pickup if you need same-day access (LillyDirect typically takes 2-5 days to ship). Use LillyDirect if you want the lowest monthly cash price. A GoodRx coupon may help at retail, though it rarely beats LillyDirect for Foundayo since LillyDirect is already at manufacturer-set floor pricing.
4. Telehealth platforms (Ro and others, rolling out)
Ro launched Foundayo on April 9, 2026 alongside the retail rollout. Other telehealth platforms (Hims & Hers, LifeMD, Lemonaid, GoodRx Care) are adding it through Q2 2026. Pricing varies by platform: expect a monthly subscription that bundles the prescriber visit, drug cost, and shipping.
Telehealth advantage: integrated prescriber visit if you do not already have a doctor managing your weight loss. Disadvantage: typically a markup over LillyDirect direct-to-consumer pricing.
- Ro - launch partner for Foundayo as of April 9, 2026
- Hims & Hers - largest telehealth GLP-1 platform by revenue, adding oral GLP-1s through Q2
- LifeMD - existing Novo Nordisk partnership; orforglipron access via Lilly partnership pending
See our full telehealth provider comparison for side-by-side pricing, drug menu, and speed-to-Rx as Foundayo coverage expands.
5. Switch options if Foundayo is not the right fit
If Foundayo's $149-$299/month range still does not work, two other cash-pay GLP-1s sit at similar price points:
- Oral Wegovy 25 mg via NovoCare at $149/month for the 1.5 / 4 mg titration doses. Same starting price, slightly lower trial efficacy (13.6% vs Foundayo's 14.7%), requires strict fasting.
- Zepbound via LillyDirect at $299/month for 2.5 mg starter vials. Much higher efficacy (22.5% in SURMOUNT-1) but requires weekly injection.
Run the comparison directly on the cheapest GLP-1 finder or full Foundayo cost guide to see your exact $/lb-lost breakdown by drug.
Frequently asked questions
How much does Foundayo cost without insurance in 2026?
LillyDirect self-pay is the cheapest cash-pay path: $149/month for the lowest dose, up to $299/month for higher doses within the 45-day refill window. For the highest doses (14.5 mg and 17.2 mg), standard pricing is $349/month if your refill window lapses. List price (WAC) is approximately $1,099/month - almost no one pays this. As of May 2026, no compounded version exists (Foundayo only launched April 1, 2026), and there is no current "branded telehealth subscription" tier comparable to the Novo Nordisk Wegovy subscription program.
What is the 45-day refill window and why does it matter?
LillyDirect prices Foundayo based on whether you refill within 45 days of your previous fill. Within the window: $149/month lowest dose, up to $299/month for higher doses. Outside the window (gap of 46+ days between fills): higher doses (14.5 mg and 17.2 mg) move to $349/month standard pricing. The window exists to keep prices low for adherent patients while discouraging stockpiling and resale. Practically: set a calendar reminder for day 30 of your supply to place the next order. If you have to pause treatment for any reason (insurance change, GI side effect titration adjustment), the lower dose tier prices stay accessible regardless.
Is Foundayo the cheapest cash-pay GLP-1 in 2026?
It is tied for cheapest at the lowest dose. Both Foundayo at LillyDirect ($149/month) and oral Wegovy 25 mg at NovoCare ($149/month for the 1.5 mg and 4 mg titration doses) start at $149/month, making them the joint cheapest branded FDA-approved GLP-1 cash-pay paths in the US. Zepbound starts at $299/month for the 2.5 mg starter vial via LillyDirect. Above the starter doses, all three rise: Foundayo to $299, oral Wegovy to $199 (4 mg post-Aug 31, 2026), Zepbound to $399-$449.
Can I buy Foundayo at CVS or Walgreens?
Yes. Retail pharmacy availability launched April 9, 2026, eight days after FDA approval. CVS, Walgreens, and most major chains carry Foundayo with a prescription. Retail cash-pay pricing varies pharmacy-to-pharmacy but is typically higher than LillyDirect because retail adds a dispensing fee and the pharmacy margin. If your priority is the lowest cash price, order through LillyDirect (lilly.com/lillydirect/medicines/foundayo) and have it shipped. If your priority is same-day access, retail pickup with a prescription works.
What about telehealth platforms?
Ro launched Foundayo on April 9, 2026 alongside the retail rollout, and other telehealth platforms are adding it through Q2 2026. Telehealth platforms typically charge a prescriber-visit fee plus the drug cost. Pricing varies by platform and changes frequently; check the platform directly for current rates. The clear advantage of telehealth is the integrated prescriber visit if you do not have an existing doctor; the disadvantage is a markup over LillyDirect direct-to-consumer pricing. We track current telehealth prices on the /telehealth page.
Will Medicare cover Foundayo?
Yes, in a limited way. Eli Lilly's announced Medicare Part D terms include eligible enrollees paying as low as $50/month beginning July 1, 2026. The Medicare Modernization Act of 2003 statutorily excludes drugs prescribed solely for weight loss from Part D, but Lilly has structured Foundayo pricing to include Medicare-eligible patients at the $50 tier. Traditional Medicare beneficiaries should verify with their Part D plan after July 1, 2026. Medicare Advantage plans handle GLP-1s plan-by-plan. Medicaid coverage is state-by-state and not yet broadly established for Foundayo.
Is there a Foundayo savings card?
Yes. The Foundayo Savings Card is live at foundayo.lilly.com/coverage-savings. If your commercial insurance covers Foundayo, the card drops your copay to as low as $25 per fill (up to $100/month savings, $1,000/year cap, 10 fills/year, expires 12/31/2026). If your commercial insurance does NOT cover Foundayo, the same card unlocks dose-tier self-pay at $149 (0.8 mg) / $199 (2.5 mg) / $299 (5.5 mg and up). Government insurance (Medicare, Medicaid, Tricare, VA) is excluded from the card by federal anti-kickback statute. See /foundayo-coupon for the full breakdown of both paths plus the separate Medicare BALANCE Model path.
Is compounded orforglipron available?
No. Compounded versions of FDA-approved drugs are only legal under specific circumstances (active FDA-declared shortage, individual-patient clinical justification, etc.). Foundayo is brand new (April 2026 approval), in full commercial supply (Eli Lilly pre-manufactured $1.5 billion in inventory ahead of launch), and there is no declared shortage. Any seller offering "compounded orforglipron" online is operating outside the FDA framework and should be treated with extreme caution.
How does Foundayo compare to compounded semaglutide or tirzepatide?
Different category. Compounded GLP-1s (semaglutide, tirzepatide) ran $199-$299/month at peak availability in 2023-2024, but the FDA ended enforcement discretion for 503B (March 2025) and 503A (February 2025) compounding of those molecules, and on April 30, 2026 the FDA proposed adding semaglutide, tirzepatide, and liraglutide to the 503B Bulks List exclusion. Practically, large-scale compounded GLP-1 telehealth is closed. Foundayo is a brand-name FDA-approved product at $149/month - it is essentially a legal replacement at the same price point as compounded GLP-1s were before the crackdown.
Should I switch from Wegovy or Zepbound to save money?
Maybe. Run the math on cost per pound lost. Trial efficacy: Zepbound 22.5% (SURMOUNT-1), Wegovy injection 14.9% (STEP-1), Foundayo 14.7% (ATTAIN-1), oral Wegovy 13.6% (OASIS-4). At equivalent cash-pay starting tiers, Foundayo and oral Wegovy are tied as cheapest; Zepbound starts higher but reaches higher peak weight loss; Wegovy injection is mid on both axes. If your goal is maximum weight loss per dollar in cash-pay, Zepbound usually wins despite higher monthly cost. If your goal is the absolute lowest monthly outlay with credible efficacy, Foundayo or oral Wegovy at $149/month is the answer. Use the /cheapest-glp1 page to see the math run on your specific weight target.
Foundayo (orforglipron) coverage by major insurer
Coverage stance and per-carrier details for Foundayo (orforglipron). Each link goes to the full prior-auth requirements, cost table, and appeal playbook for that carrier.
Related guides
Track Foundayo (orforglipron) pricing and availability
Eli Lilly's daily oral pill Foundayo (orforglipron) was FDA-approved April 1, 2026 and starts at $149/mo via LillyDirect. We'll email you when pricing tiers change, insurance coverage expands, or new head-to-head data lands vs. Wegovy and Zepbound.